
Inor Medical Products Limited
Produces orthopedic implants and instruments using various materials, including chemicals, resins, and plastics.
Produces orthopedic implants and instruments using various materials, including chemicals, resins, and plastics.
Inor Medical Products Limited (IMPL) was founded in India on 29 December 1972 and has a glorious history of 52 years and three months.Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.80 M.
The company currently has active open charges totaling ₹1.65 Cr. The company has closed loans amounting to ₹2.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nitin Datanwala, Lalita Rajesh, Murli Purohit, and One other member serve as directors at the Company.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
U51100MH1972PLC016213
016213
Public Limited Indian Non-Government Company
29 Dec 1972
30 Sep 2023
31 Mar 2023
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nitin Datanwala ![]() | Director | 14-Mar-2007 | Current |
Lalita Rajesh ![]() | Additional Director | 25-Apr-2024 | Current |
Murli Purohit ![]() | Additional Director | 25-Apr-2024 | Current |
Alok Sureka ![]() | Additional Director | 25-Apr-2024 | Current |
Inor Medical Products Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 47.3% decrease. The company also saw a slight improvement in profitability, with a 8.27% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.88%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Inor Medical Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Nitin Datanwala is a mutual person
Nitin Datanwala is a mutual person
Lalita Rajesh, Murli Purohit and 1 more are mutual person
Nitin Datanwala is a mutual person
Nitin Datanwala is a mutual person
Nitin Datanwala is a mutual person
₹16.50 M
₹22.50 M
Date | Lender | Amount | Status |
---|---|---|---|
19 Dec 1997 | Icici Banking Corpn Ltd | ₹1.10 Cr | Open |
20 Jul 1993 | Corporation Bank | ₹1.50 M | Open |
21 Jul 1987 | The British Bank Of Middle East | ₹2.00 M | Open |
27 Jul 1974 | Union Bank Of India | ₹2.00 M | Open |
11 Apr 2001 | Canara Bank | ₹2.25 Cr | Satisfied |
Unlock and access historical data on people associated with Inor Medical Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Inor Medical Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inor Medical Products's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Lalita Rajesh was appointed as a Additional Director was appointed as a Additional Director on 25 Apr 2024 & has been associated with this company since 11 months 8 days .
Murli Manohar Purohit was appointed as a Additional Director was appointed as a Additional Director on 25 Apr 2024 & has been associated with this company since 11 months 8 days .
Alok Dayanand Sureka was appointed as a Additional Director was appointed as a Additional Director on 25 Apr 2024 & has been associated with this company since 11 months 8 days .
Inor Medical Products Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Inor Medical Products Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
A charge registered on 11 Apr 2001 via Charge ID 90229672 with Canara Bank was fully satisfied on 20 Dec 2019.
Inor Medical Products Limited was incorporated on 29 Dec 1972.
The authorized share capital of Inor Medical Products Limited is ₹ 5.00 M and paid-up capital is ₹ 4.80 M.
Currently 4 directors are associated with Inor Medical Products Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Inor Medical Products Limited is 47 A-Z Industrial Estateg Kadam Marg Lower Parel India, Mumbai, Maharashtra, 400013.
The corporate identification number (CIN) of Inor Medical Products Limited is U51100MH1972PLC016213 and the company number is 016213 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Inor Medical Products Limited has fallen by -47.30%.
The financial reports for the fiscal year 2023 indicates that The net worth of Inor Medical Products Limited has experienced an downturn of -11.88%.
As per the financial statements for fiscal Year 2023, The total open charges for Inor Medical Products Limited amount to ₹ 1.65 Cr.
The most recent Balance Sheet for Inor Medical Products Limited was filed with the ROC on 31 Mar 2023.
AP
DB
SD
JR
SM
SK
AC
HB